Steriwave
Commercial- Indications
- Nasal decolonization, Surgical site infection prevention
Company intelligence / Profile preview
Steriwave™, the company’s lead product for nasal decolonization using photodisinfection technology, has demonstrated significant reductions in healthcare-associated infection rates—over 80% reduction in surgical site infections at Vancouver General Hospital. Other programs are advancing through pre-clinical and clinical development targeting additional anti-infective indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ondine Biomedical.